| Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 | Dec'16 | Sep'16 | Jun'16 | Mar'16 |
|---|---|---|---|---|---|---|---|---|---|
IPO [Member] | |||||||||
Private Placement [Member] | |||||||||
Operating activities: | |||||||||
Net loss | |||||||||
-12,787 | -14,081 | -16,289 | -17,512 | -14,875 | -47,712 | -3,691 | -3,262 | -3,683 | -1,909 |
Adjustments to reconcile net loss to net cash from operating activities: | |||||||||
Research and development expense settled by shares issuance | |||||||||
0 | 0 | 0 | 0 | 0 | 42,259 | 0 | 0 | 0 | 0 |
Share-based compensation | |||||||||
992 | 4,201 | 3,821 | 10,106 | 8,756 | 0 | - | - | - | - |
Depreciation expense | |||||||||
8 | 12 | 10 | 9 | 7 | 6 | 4 | 5 | 4 | 5 |
Changes in operating assets and liabilities: | |||||||||
Advances to suppliers | |||||||||
371 | -61 | -490 | 739 | 360 | 117 | 50 | 545 | 94 | 21 |
Government grants | |||||||||
0 | -307 | - | - | 0 | 0 | - | - | - | - |
Prepaid expenses | |||||||||
- | - | - | - | - | - | - | 0 | 0 | 0 |
Other current assets | |||||||||
- | - | - | - | - | - | - | 5 | 11 | 11 |
Prepaid expenses and other current assets | |||||||||
241 | 20 | - | - | 380 | -175 | - | - | - | - |
Other noncurrent assets | |||||||||
100 | 122 | 85 | 66 | 7 | 82 | 35 | 54 | 5 | 27 |
Accounts payable | |||||||||
-1,585 | 1,010 | 2,354 | -1,005 | 1,018 | 568 | -997 | 149 | 877 | 115 |
Accrued expenses | |||||||||
814 | 305 | -515 | 738 | 573 | -97 | -143 | 249 | -88 | -120 |
Amounts due to related parties | |||||||||
0 | 0 | -2 | 0 | -5 | -203 | -154 | -48 | 4 | -24 |
Other current liabilities | |||||||||
169 | 2 | -133 | 131 | 142 | -76 | 143 | 61 | -31 | 1 |
Net cash used in operating activities | |||||||||
-13,101 | -8,939 | -10,182 | -8,204 | -5,131 | -5,279 | - | - | - | - |
Investing activities: | |||||||||
Net cash used in operating activities | |||||||||
- | - | - | - | - | - | - | - | -3,027 | -1,991 |
Acquisitions of property and equipment | |||||||||
0 | 13 | 8 | 48 | 6 | 14 | -25 | 55 | 34 | 0 |
Net cash used in investing activities | |||||||||
0 | -13 | -76 | -3,054 | -6 | -14 | - | - | - | - |
Financing activities: | |||||||||
Net cash used in investing activities | |||||||||
- | - | - | - | - | - | - | - | -34 | 0 |
Proceeds from issuance of ordinary shares, net of underwriting discount | |||||||||
14,000 | 0 | 0 | 0 | 0 | 50,505 | 0 | 15,250 | 0 | 0 |
Payment of offering costs | |||||||||
- | 0 | - | - | - | 2,334 | 390 | 57 | 48 | 42 |
Net cash provided by financing activities | |||||||||
13,829 | 0 | 0 | 0 | -449 | 48,171 | - | - | - | - |
Effect of foreign exchange rate changes, net | |||||||||
335 | -179 | 21 | -4 | 2 | -1 | - | - | - | - |
Net cash (used in) provided by financing activities | |||||||||
- | - | - | - | - | - | - | - | -48 | -42 |
Effect of foreign exchange rate changes, net | |||||||||
- | - | - | - | - | - | - | - | -54 | 7 |
Net increase/(decrease) in cash | |||||||||
1,063 | -9,131 | -10,237 | -11,262 | -5,584 | 42,877 | -5,642 | 11,697 | -3,163 | -2,026 |
Non-cash activities: | |||||||||
Initial public offering costs accrued in accrued expenses and other current liabilities | |||||||||
- | - | - | - | - | - | 714 | 0 | 555 | 55 |
Research and development expense settled by shares issuance | |||||||||
0 | 0 | 0 | 0 | 0 | 42,259 | 0 | 0 | 0 | 0 |